What is Mithradote Bio?
Mithradote Bio, based in San Diego, California, is a biotechnology firm dedicated to developing a critical antidote against drink spiking. This innovative focus positions the company at the intersection of public health and advanced pharmaceutical research, aiming to provide a tangible solution to a pervasive societal issue. The company's work is crucial in enhancing safety and security in social environments.
How much funding has Mithradote Bio raised?
Mithradote Bio has raised a total of $1M across 1 funding round:
Angel/Seed
$1M
Angel/Seed (2024): $1M with participation from Vickers Venture Partners
Key Investors in Mithradote Bio
Vickers Venture Partners
Vickers Venture Partners is a global venture capital firm known for its investments in deep technology. With a history of backing successful companies, they bring significant expertise in scaling innovative ventures.
What's next for Mithradote Bio?
With this recent strategic investment, Mithradote Bio is poised to accelerate its research and development efforts. The capital infusion will likely support further clinical trials, expand its scientific team, and potentially scale up manufacturing capabilities. This funding round signals strong confidence in the company's technology and its potential to make a significant impact on public safety, paving the way for broader market penetration and the establishment of industry-leading safety protocols.
See full Mithradote Bio company page
